Epilog, a spin-off from imec and Ghent University, is launching its platform that improves epilepsy diagnosis through an automated service that accurately and efficiently analyzes large amounts of EEG-data. The new platform enables doctors to make well-informed patient treatment decisions. Proven in clinical trials and welcomed by the physician community, interest in Epilog has grown internationally, and to-date, the solution is being tested in seven hospitals within Europe.
